Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

639
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
639
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

5.2K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.2K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

1.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.7K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.7K
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

12.5K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

CA19-9 induces microenvironment remodeling in pancreatic ductal adenocarcinoma.

bioRxiv : the preprint server for biology·2026
Same author

NDRG3 is essential for sustaining antigen-driven T cell responses by protecting against restimulation-induced cell death.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Derivation of functional early gestation decidual natural killer cell subtypes from induced pluripotent stem cells.

Stem cells (Dayton, Ohio)·2026
Same author

Publisher Correction: Atlas-guided discovery of transcription factors for T cell programming.

Nature·2026
Same author

The CD8 immgenT framework as a universal reference of mouse CD8αβ T cell differentiation states.

bioRxiv : the preprint server for biology·2026
Same author

Atlas-guided discovery of transcription factors for T cell programming.

Nature·2026

相关实验视频

Updated: Aug 25, 2025

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
06:32

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

2.2K

快照:癌症免疫编辑

Siva Karthik Varanasi1, Susan M Kaech1, Jack D Bui2

  • 1The Salk Institute for Biological Studies, La Jolla, CA 92037, USA.

Cell
|October 14, 2022
PubMed
概括

癌症免疫编辑涉及免疫和瘤细胞之间的相互作用,改变瘤特征. 这项研究比较了自然和治疗诱导的癌症免疫编辑,详细介绍了影响瘤回归或进展的因素.

科学领域:

  • 癌症学
  • 免疫学
  • 癌症生物学

背景情况:

  • 瘤微环境是一个复杂的生态系统,
  • 癌症免疫编辑描述了免疫系统和癌细胞之间的动态相互作用,影响瘤的进化.
  • 这种过程可以导致瘤的消除,休眠状态,或瘤的逃生和进展.

研究的目的:

  • 为了比较内源性 (自然) 和治疗诱导的癌症免疫编辑.
  • 概述这些相互作用的分子和细胞机制.
  • 要区分导致瘤完全退缩与瘤逃生和进展的因素.

主要方法:

  • 分子和细胞特征的比较分析.
  • 对癌症免疫编辑的现有文献和数据的审查.
  • 专注于基因表达,新陈代谢,突变负担和细胞性变化.

主要成果:

  • 不同的分子和细胞特征是内源与治疗诱导的免疫编辑的特征.
  • 特定的相互作用可以促进瘤回归或促进瘤脱离.
  • 瘤微环境成分的变化是决定结果的关键因素.

结论:

更多相关视频

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

621
Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
12:19

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

1.2K

相关实验视频

Last Updated: Aug 25, 2025

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
06:32

Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors

Published on: August 18, 2023

2.2K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

621
Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics
12:19

Monitoring the Cancer-Immunity Cycle and Exploring Tumor Microenvironment Dynamics

Published on: June 7, 2024

1.2K
  • 了解癌症免疫编辑的细微差别对于开发有效的癌症治疗至关重要.
  • 与内源性过程相比,治疗诱导的免疫编辑具有独特的目标和挑战.
  • 根据免疫编辑动态定制治疗策略可能会改善患者的治疗结果.